stockrow
Friday 6 November 2026
Export INCR’s income statement to Excel — free account
InterCure Ltd.
INCR Healthcare Drug Manufacturers Specialty & Generic
InterCure Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $78.5 million, up 18.4% from fiscal 2024.
3.27
0.03
−0.91%
Follow INCR
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 1 | 3 | 5 | 6 | — | — | — | — | — |
P/E ratio |
1.72 | 3.00 | 2.46 | 2.22 | 41.20 | 50.92 | 50.92 | — | — | — |
Altman Z-Score |
(0.13) | (0.13) | 0.29 | 0.77 | 0.76 | 8.89 | — | — | — | — |
P/S ratio |
0.06 | 0.11 | 0.09 | 0.27 | 4.21 | 0.00 | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
0.64 | 0.79 | 1.86 | 2.46 | 2.88 | 7.54 | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 3.43 | 37.38 | 0.00 | 0.00 | — | — | — |
Beneish M-Score |
(2.77) | (1.90) | (1.94) | (1.58) | (1.21) | 1.96 | — | — | — | — |
P/Operating CF |
2.28 | (0.92) | (0.75) | 2.50 | 158.67 | 59.92 | (146.18) | — | — | — |
P/B ratio |
0.06 | 0.11 | 0.08 | 0.21 | 2.02 | 2.05 | 2.73 | — | — | — |
Price to Tangible BV |
0.13 | 0.21 | 0.17 | 0.46 | 4.77 | 6.66 | 12.55 | — | — | — |
EV/Sales |
0.39 | 0.40 | 0.24 | (0.04) | 3.70 | 0.00 | 0.00 | — | — | — |
EV/EBITDA |
4.29 | 4.40 | 2.71 | 0.00 | 20.12 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
16.00 | (186.89) | (115.03) | (0.29) | 32.90 | 0.00 | 0.00 | — | — | — |
EV/FCF |
(57.90) | (11.46) | (7.05) | (0.47) | 32.90 | 0.00 | 0.00 | — | — | — |
Quick Ratio |
0.97 | 1.18 | 1.38 | 1.22 | 1.39 | 1.80 | 1.51 | 0.31 | 0.76 | 0.89 |
Current Ratio |
1.48 | 1.73 | 1.85 | 1.62 | 1.74 | 2.57 | 1.86 | 0.31 | 0.76 | 0.89 |
Net Debt/EBITDA |
(4.07) | (1.10) | 0.29 | (1.97) | (5.13) | (6.30) | 0.13 | (0.93) | (0.43) | 0.00 |
Debt/Assets |
13.03% | 17.99% | 13.07% | 12.93% | 5.11% | 2.05% | 6.04% | 35.57% | 0.00% | 8.63% |
Debt/Equity |
0.23 | 0.35 | 0.23 | 0.24 | 0.08 | 0.02 | 0.07 | 0.65 | 0.14 | 0.10 |
Asset Turnover |
0.39 | 0.32 | 0.39 | 0.48 | 0.45 | 0.22 | 0.06 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
(0.47) | 0.99 | 0.87 | 1.14 | 5.33 | (0.21) | 1.96 | 0.12 | 0.18 | (4.41) |
Capex/Depreciation |
(0.21) | (0.31) | (0.20) | (1.69) | (1.90) | 0.00 | 0.00 | 0.00 | 0.00 | — |
Interest Coverage |
(1.37) | (2.94) | (1.62) | 3.39 | 2.94 | 0.89 | 0.00 | (18.92) | (1.75) | (5.73) |
| (9.32%) | (15.82%) | (12.04%) | 8.98% | 1.28% | (14.54%) | (4.30%) | (60.96%) | (25.66%) | 1.13% | |
| (5.10%) | (8.73%) | (6.74%) | 5.36% | 0.92% | (12.66%) | (3.74%) | (40.62%) | (43.41%) | 0.98% | |
ROIC |
(3.90%) | (9.23%) | (5.79%) | 7.94% | 6.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(17.40%) | (25.08%) | (21.34%) | 15.04% | 2.05% | (37.14%) | (11.39%) | 114.13% | 696.74% | (69.53%) |
Average Days of Receivables |
216.12 | 277.51 | 206.73 | 122.01 | 81.71 | 86.19 | 270.13 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.14% | 0.17% | 0.11% | 0.16% | 0.55% | 2.42% | 19.16% | — | — | — |
Selling, General and Administrative Expense of Revenue |
35.47% | 44.91% | 27.67% | 25.27% | 25.14% | 40.43% | 924.25% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.32 | 0.29 | 0.28 | 0.30 | 0.38 | 0.58 | 0.60 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.90% | 0.93% | 0.73% | 2.22% | 2.85% | 0.00% | 0.00% | — | — | — |
Graham Net Nets |
1.96 | 1.81 | 1.98 | 0.66 | 0.12 | 0.08 | 0.01 | — | — | — |
Graham Number |
— | 0.00 | 0.00 | 24.83 | 3.37 | 0.00 | 0.00 | — | — | — |
Earnings Yield |
58.19% | 33.30% | 40.73% | 45.07% | 2.43% | 1.96% | 1.96% | — | — | — |
Free Cash Flow Yield |
(10.35%) | (30.67%) | (37.51%) | 29.18% | 2.68% | 0.00% | 0.00% | — | — | — |
Revenue per Share |
7.30 | 7.23 | 10.60 | 13.20 | 9.10 | 0.80 | 0.11 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
0.46 | (1.97) | (1.60) | 1.68 | 1.01 | 0.10 | (0.14) | (0.02) | (0.02) | (0.02) |
Capex per Share |
(0.10) | (0.14) | (0.08) | (0.65) | (0.56) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.36 | (2.11) | (1.68) | 1.04 | 0.44 | 0.10 | (0.14) | (0.02) | (0.02) | (0.02) |
Cash per Share |
1.32 | 2.36 | 3.31 | 8.11 | 8.75 | 0.47 | 0.34 | 0.05 | 0.04 | 0.07 |
Shareholders Equity per Share |
10.71 | 11.71 | 13.62 | 17.13 | 18.46 | 3.37 | 3.18 | 0.29 | 0.35 | 0.50 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.71 | 11.71 | 13.62 | 17.13 | 18.46 | 3.37 | 3.18 | 0.29 | 0.35 | 0.50 |
Free Cash Flow |
3.86 | (19.39) | (15.27) | 9.39 | 3.40 | 2.43 | (3.34) | (0.40) | (0.27) | (0.30) |
Working Capital |
29.74 | 44.60 | 52.40 | 58.04 | 44.13 | 14.57 | 5.66 | (3.01) | (0.23) | (0.10) |
Capital Expenditures |
(1.03) | (1.30) | (0.70) | (5.88) | (4.34) | (6.49) | (8.13) | (0.02) | — | 0.00 |
Net Current Asset Value |
6.55 | 7.27 | 24.24 | 21.15 | 33.74 | 13.24 | 4.68 | (3.01) | (0.23) | (0.10) |
EV/EBIT |
4.44 | 4.55 | 2.80 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.01 | 0.02 | 0.01 | 0.05 | 0.06 | 0.00 | 0.00 | — | — | — |
Price to Operating Income |
0.74 | 1.30 | 1.06 | 2.13 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.17 | 0.15 | 0.14 | 0.11 | 0.09 | 0.06 | 0.03 | 0.12 | 1.03 | 0.00 |
Cash ROIC |
2.48% | (11.67%) | (8.38%) | 3.53% | 1.54% | 2.44% | (3.85%) | (4.12%) | (3.66%) | (3.93%) |
Accounts Receivable Turnover |
1.62 | 1.26 | 2.04 | 4.30 | 6.84 | 6.05 | 2.29 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.38 | 2.75 | 2.31 | 2.56 | 3.25 | 3.05 | 3.02 | 0.00 | 0.00 | — |
Inventory Turnover |
2.11 | 1.85 | 2.05 | 2.50 | 2.98 | 2.51 | 0.51 | 0.00 | 0.00 | — |
Average Days of Payables |
104.93 | 131.59 | 114.19 | 186.55 | 174.16 | 192.04 | 232.15 | 8,285.50 | 0.00 | — |
Days of Inventory on Hand |
166.40 | 212.70 | 154.74 | 187.19 | 183.36 | 232.43 | 286.58 | 0.00 | 0.00 | — |
Average Receivables |
48.43 | 52.56 | 47.38 | 27.85 | 10.23 | 3.35 | 1.13 | 0.18 | 0.01 | 0.01 |
Average Payables |
20.37 | 21.13 | 29.44 | 28.76 | 12.88 | 3.61 | 0.74 | 0.74 | — | — |
Average Inventory |
32.63 | 31.37 | 33.28 | 29.35 | 14.02 | 4.39 | 4.39 | — | — | — |
Average Assets |
203.33 | 209.85 | 249.57 | 248.95 | 157.03 | 91.61 | 45.57 | 8.40 | 3.61 | 7.06 |
Average Common Equity |
111.30 | 115.79 | 139.77 | 148.76 | 113.82 | 79.75 | 39.61 | 5.60 | 6.11 | 6.11 |
Columns are period end dates · fundamentals updated 26 Oct 2026